Michele Soares Gomes-Gouvêa Selected Research

Michele Soares Gomes-Gouvêa Research Topics

3	COVID-19 12/2021 - 11/2020
3	Yellow Fever 11/2019 - 01/2019
3	Hepatitis B 12/2015 - 02/2010
2	Persistent Infection 01/2018 - 08/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 12/2015
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Massive Hepatic Necrosis 01/2019
1	Pancreatitis 01/2019
1	Coinfection 01/2018
1	Infections 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2016
1	Chronic Hepatitis B 06/2014
1	Sepsis (Septicemia) 01/2013
1	Candidemia 01/2013
1	Hepatitis D 08/2011
1	Viremia 09/2010

2	EnzymesIBA 01/2018 - 01/2018
1	Hazardous Substances (Hazardous Materials)IBA 12/2021
1	Biological ProductsIBA 01/2021
1	SofosbuvirIBA 11/2019
1	Transaminases (Aminotransferases)IBA 01/2019
1	AmmoniaIBA 01/2019
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2019
1	BilirubinIBA 01/2019
1	Factor V (Coagulation Factor V)IBA 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Immunoglobulin M (IgM)IBA 01/2018
1	AntibodiesIBA 01/2018
1	VaccinesIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2018
1	Antiviral Agents (Antivirals)IBA 08/2016
1	Interferon LambdaIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	Hepatitis B e AntigensIBA 06/2014
1	Fluconazole (Zonal)FDA LinkGeneric 01/2013
1	NucleotidesIBA 08/2011
1	lipoarabinomannan (LAM)IBA 09/2010
1	Lamivudine (Epivir)FDA Link 09/2010
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2010
1	DNA (Deoxyribonucleic Acid)IBA 02/2010